Loading clinical trials...
Loading clinical trials...
Patients with infantile or late infantile NCL have either a reduced amount of, or are missing, the palmitoyl protein thioesterase 1 (PPT1) enzyme or the tripeptidyl peptidase 1 (TPP-I) enzyme. Human c...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
StemCells, Inc.
NCT03307304 · Juvenile Neuronal Ceroid Lipofuscinosis (CLN3), Batten Disease
NCT01873924 · Neuronal Ceroid Lipofuscinosis, Neuronal Ceroid Lipofuscinosis CLN1, and more
NCT06844877 · Neuronal Ceroid Lipofuscinosis
NCT04476862 · Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2
NCT05152914 · Neuronal Ceroid Lipofuscinosis Type 2
Oregon Health and Science University
Portland, Oregon
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions